NeuroOne Medical Technologies Corporation (NMTC) Return on equity 2021–2025
NeuroOne Medical Technologies Corporation (NMTC) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-51.0%FY2025 · since FY2021: -151.8% → -51.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -51.0% | +1447.6 pp |
| FY2024 | -1498.5% | -1308.8 pp |
| FY2023 | -189.8% | -85.7 pp |
| FY2022 | -104.1% | +47.7 pp |
| FY2021 | -151.8% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More NMTC financial trends
NMTC RevenueNMTC Net incomeNMTC Net marginNMTC Gross profitNMTC Gross marginNMTC Operating incomeNMTC Operating marginNMTC Operating cash flowNMTC Free cash flowNMTC Capital expendituresNMTC Stock buybacksNMTC Dividends paidNMTC Total assetsNMTC Total liabilitiesNMTC Shareholders’ equityNMTC overview →